Skip to content

A randomized controlled trial for the Efficacy of Ultra Short Wave Electrotherapy in the treatment of Novel Coronavirus Pneumonia (COVID-19)

A randomized controlled trial for the Efficacy of Ultra Short Wave Electrotherapy in the treatment of Novel Coronavirus Pneumonia (COVID-19)

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000029972
Enrollment
Unknown
Registered
2020-02-17
Start date
2020-02-17
Completion date
Unknown
Last updated
2021-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

Experimental group:ultra short wave diathermy, 10 minutes twice daily for 12 consecutive days
control:standard medical therapy

Sponsors

Tongji Hospital, Tongji Medical College,Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) Aged 18-65 years; (2) Virus nucleic acid test is positive; (3) Lung CT showed multiple patchy, lumpy ground glass opacity(GGO), consolidation or other typical manifestations in both lungs .

Exclusion criteria

Exclusion criteria: (1) Positive for other pathogens such as A, B, Mycoplasma, Adenovirus; (2) patients require mechanical ventilation; (3) People with metal or pacemaker; (4) active tuberculosis; (5) Massive pulmonary fibrosis; (6) Those with shock; (7) Those who have bleeding tendency or active bleeding in the lungs; (8) Patients with multiple organ failure who need ICU monitoring and treatment; (9) Patients with tumor and severe basic diseases; (10) pregnant or lactating women; (11) Patients with active tuberculosis; (12) Those with other contraindications to ultrashort wave; (13) Patients with severe cognitive impairment who cannot follow the instructions to complete the treatment; (14) Those without signed informed consent; (15) Researchers believe that other reasons are not suitable for clinical trials.

Design outcomes

Primary

MeasureTime frame
the rate of Coronary virus nucleic acid negative at 7 days, 14 days, 21 days, and 28 days after Ultra Short Wave Electrotherapy;systemic inflammatory response syndrome (SIRS) scores at 7 days, 14 days, 21 days, and 28 days after Ultra Short Wave Electrotherapy;

Secondary

MeasureTime frame
time to clinical recovey;the seven-category?ordinal scores at 7 days, 14 days, 21 days, and 28 days after Ultra Short Wave Electrotherapy;

Countries

China

Contacts

Public ContactChen Hong

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology

chenhong1129@hotmail.com+86 13296508243

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 26, 2026